Drug sensitivity prediction with normal inverse Gaussian shrinkage informed by external data

DOI10.1002/bimj.201900371zbMath1523.62172OpenAlexW3044067174WikidataQ101405336 ScholiaQ101405336MaRDI QIDQ6071297

Mark A. van de Wiel, Gwenaël G. R. Leday, Magnus M. Münch, Sylvia Richardson

Publication date: 23 November 2023

Published in: Biometrical Journal (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1002/bimj.201900371

zbMATH Keywords

empirical Bayesvariational Bayesdrug sensitivityGenomics of Drug Sensitivity in Cancer (GDSC) data

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Unnamed Item
• Unnamed Item
• Unnamed Item
• Unnamed Item
• Unnamed Item
• Mean-field variational approximate Bayesian inference for latent variable models
• Statistical properties of the generalized inverse Gaussian distribution
• Gene network reconstruction using global-local shrinkage priors
• Approximate Bayesian Inference for Latent Gaussian models by using Integrated Nested Laplace Approximations
• Normal Inverse Gaussian Distributions and Stochastic Volatility Modelling
• The Selection of Prior Distributions by Formal Rules
• Learning from a lot: Empirical Bayes for high‐dimensional model‐based prediction
• On the specification of prior distributions for variance components in disease mapping models
• Bayesian Hierarchical Varying-Sparsity Regression Models with Application to Cancer Proteogenomics
• An empirical Bayes approach to network recovery using external knowledge
• Decoupling Shrinkage and Selection in Bayesian Linear Models: A Posterior Summary Perspective
• Empirical Bayes Gibbs sampling
• An invariant form for the prior probability in estimation problems
• Prior distributions for variance parameters in hierarchical models (Comment on article by Browne and Draper)

This page was built for publication: Drug sensitivity prediction with normal inverse Gaussian shrinkage informed by external data